Research
Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort
BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c4444 (Published 02 September 2010) Cite this as: BMJ 2010;341:c4444Related articles
- Editorial Published: 02 September 2010; BMJ 341 doi:10.1136/bmj.c4506
- Views & Reviews Published: 06 October 2010; BMJ 341 doi:10.1136/bmj.c5506
- Research Published: 16 January 2013; BMJ 346 doi:10.1136/bmj.f114
- Letter Published: 26 October 2010; BMJ 341 doi:10.1136/bmj.c5980
- Research Published: 29 November 2007; BMJ 335 doi:10.1136/bmj.39367.495995.AE
- RESEARCH Published: 07 November 2007; BMJ doi:10.1136/bmj.39367.495995.AE
- Student Published: 16 November 2010; BMJ 341 doi:10.1136/sbmj.c6420
See more
- StatinsBMJ January 24, 2024, 384 e072584; DOI: https://doi.org/10.1136/bmj-2022-072584
- Proton pump inhibitorsBMJ November 13, 2023, 383 e070752; DOI: https://doi.org/10.1136/bmj-2022-070752
- Recognition and initial management of ovarian torsionBMJ April 28, 2023, 381 e074514; DOI: https://doi.org/10.1136/bmj-2022-074514
- Aortic stenosisBMJ March 15, 2023, 380 e070511; DOI: https://doi.org/10.1136/bmj-2022-070511
- Human monkeypox: diagnosis and managementBMJ February 06, 2023, 380 e073352; DOI: https://doi.org/10.1136/bmj-2022-073352
Cited by...
- Prophylactic efficacy on periprosthetic bone loss in calcar region after total hip arthroplasty of antiosteoporotic drugs: a network meta-analysis of randomised controlled studies
- Evaluation of exposure to pioglitazone and risk of prostate cancer: a nested case-control study
- Bisphosphonates and evidence for association with esophageal and gastric cancer: a systematic review and meta-analysis
- Drug therapies in older adults (part 1)
- Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)
- Obesity, Bisphosphonates, and Colorectal Cancer
- Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis
- Exposure to bisphosphonates and risk of gastrointestinal cancers: series of nested case-control studies with QResearch and CPRD data
- Oral Bisphosphonates and Risk of Esophageal Cancer: A Dose-Intensity Analysis in a Nationwide Population
- Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study
- Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database
- Use of Bisphosphonates and Reduced Risk of Colorectal Cancer
- Long-term use of oral bisphosphonates increases the risk of oesophageal but not gastric or colorectal cancer
- 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
- Two studies, same data source, two answers
- Rosiglitazone and the need for a new drug safety agency
- More data using same database
- Oral Bisphosphonate Use Is Associated with Esophageal Cancer
- Is Bisphosphonate Use Associated with Risk for Esophageal Cancer?
- Oral bisphosphonates and oesophageal cancer
- Case-control analysis within a UK primary care cohort: oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum